Short answer

Incorporate the A6MCT as a standard assessment for upper limb endurance when designing or evaluating products and interventions for non-ambulatory individuals with neuromuscular conditions.

Field
Human Factors
Source
Journal of Clinical Medicine (2023)
Method
Prospective observational study
Sample
38 participants
Evidence
Strong effect

The Assisted Six-Minute Cycling Test (A6MCT) is a feasible and effective tool for assessing upper limb endurance in non-ambulatory individuals with Spinal Muscular Atrophy (SMA). This human factors research insight is drawn from a 2023 study published in Journal of Clinical Medicine. Using Prospective observational study with 38 participants, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Incorporate the A6MCT as a standard assessment for upper limb endurance when designing or evaluating products and interventions for non-ambulatory individuals with neuromuscular conditions.

Study
Human FactorsRecentStrong effect

Assisted Cycling Test Accurately Measures Endurance in Non-Ambulatory Individuals

The Assisted Six-Minute Cycling Test (A6MCT) is a feasible and effective tool for assessing upper limb endurance in non-ambulatory individuals with Spinal Muscular Atrophy (SMA).

Journal of Clinical Medicine · 2023

01

Key Findings

  • 01The A6MCT was feasible for 95% of participants.
  • 02The A6MCT discriminated between different functional groups within the SMA population.
  • 03A6MCT results were significantly associated with other established clinical measures of function and disease severity.
02

Application

Design takeaway

Incorporate the A6MCT as a standard assessment for upper limb endurance when designing or evaluating products and interventions for non-ambulatory individuals with neuromuscular conditions.

How to apply

When designing assistive devices or rehabilitation tools for individuals with limited mobility, use the A6MCT to objectively quantify improvements in endurance and functional capacity.

Project actions

  • 01Consider how to measure endurance in users with specific physical limitations.
  • 02Explore existing clinical tests that can be adapted for your design project's evaluation.
03

Method & Evidence

AimTo assess the feasibility, clinical discrimination, and associations of the Assisted Six-Minute Cycling Test (A6MCT) as a measure of endurance in non-ambulatory patients with Spinal Muscular Atrophy (SMA).
MethodProspective observational study
ProcedureParticipants with SMA performed the A6MCT, along with other clinical assessments (RULM, ATEND, EK2). Perceived fatigue (FSS) and exertion (RPE) were also recorded. Data were analyzed for feasibility, ability to discriminate between functional groups, and correlations with other clinical measures.
Sample38 participants
ContextClinical assessment of neuromuscular disorders

Variables

IVAssisted Six-Minute Cycling Test (A6MCT)
DVFeasibility, clinical discrimination, associations with other clinical measures (RULM, ATEND, EK2, Brooke), perceived fatigue (FSS), perceived exertion (RPE).
CVAge, SMA classification (sitter/non-sitter), specific SMA type (implied by disease progression).
04

Strengths & Limitations

Strengths

  • +Inclusion of multiple established clinical measures for comparison.
  • +Assessment of both objective performance and subjective experience (fatigue, exertion).

Limitations

The study involved a relatively small sample size, and the findings may not be generalizable to all individuals with SMA or other neuromuscular conditions.

Reliability & validity

The study demonstrates good feasibility and significant associations with other validated clinical measures, suggesting good concurrent validity. Reliability would need further testing through repeated measures.

Think critically

How might the results of the A6MCT be influenced by factors not explicitly controlled for in this study, such as motivation or specific disease progression rates within the SMA spectrum?

05

Design Principles

"Objective measurement of functional capacity is essential for evaluating the impact of design interventions on user performance and well-being."

Developing reliable methods to measure endurance in populations with limited mobility is crucial for understanding disease progression and evaluating the effectiveness of interventions. The A6MCT provides a standardized, objective measure that can inform design decisions for assistive devices and rehabilitation strategies.

06

What This Means for Your Design

A special bike test using your arms can accurately measure how long people with SMA who can't walk can keep going, and it works well with other tests doctors use.

How to use in your project

  • 1.Use this study to justify the selection of specific outcome measures for assessing user performance in your design project.
  • 2.Reference the A6MCT as a validated method for evaluating endurance in similar user groups.
07

Add to My Project

08

Quick Cite

Paragraph starter

The Assisted Six-Minute Cycling Test (A6MCT) has demonstrated feasibility and validity in measuring upper limb endurance for non-ambulatory individuals with Spinal Muscular Atrophy (SMA), correlating significantly with other clinical assessments. This suggests its utility as an outcome measure for evaluating design interventions aimed at improving functional capacity in similar populations.

09

Source

Journal of Clinical Medicine

Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)

journal · 2023

View source

Questions About This Research

What does the research say about assisted cycling test accurately measures endurance in non-ambulatory individuals?
Incorporate the A6MCT as a standard assessment for upper limb endurance when designing or evaluating products and interventions for non-ambulatory individuals with neuromuscular conditions. Evidence: Journal of Clinical Medicine (2023).
Why does "Assisted Cycling Test Accurately Measures Endurance in Non-Ambulatory Individuals" matter for design?
Developing reliable methods to measure endurance in populations with limited mobility is crucial for understanding disease progression and evaluating the effectiveness of interventions. The A6MCT provides a standardized, objective measure that can inform design decisions for assistive devices and rehabilitation strategies.
How can designers apply this research?
Incorporate the A6MCT as a standard assessment for upper limb endurance when designing or evaluating products and interventions for non-ambulatory individuals with neuromuscular conditions.
What were the main findings?
The A6MCT was feasible for 95% of participants.. The A6MCT discriminated between different functional groups within the SMA population.. A6MCT results were significantly associated with other established clinical measures of function and disease severity.
What research method was used?
Prospective observational study with 38 participants.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2023 journal from Journal of Clinical Medicine.
What should I do differently in my next project?
When designing assistive devices or rehabilitation tools for individuals with limited mobility, use the A6MCT to objectively quantify improvements in endurance and functional capacity.
What are the limitations?
Further validation with a larger and more diverse dataset is recommended for broader applicability.